FdaApplication

BLA 125036

Back to search

Identifiers

Properties

PropertyValue
applicant_nameAstellas Pharma US, Inc.
application_typeBLA
approval_date2003-01-30

Products (2)

ProductActive ingredientStrengthDosage form
AMEVIVE—7.5MGFor Injection
AMEVIVE—15MGFor Injection

2 products